{
    "organizations": [],
    "uuid": "ba0c0714f3d39e2fda30379a9a929b760cbab5bb",
    "author": "",
    "url": "https://www.reuters.com/article/brief-celsion-phase-iii-clinical-study-o/brief-celsion-phase-iii-clinical-study-of-thermodox-in-combination-with-radiofrequency-ablation-to-continue-according-to-protocol-idUSFWN1RM0N4",
    "ord_in_thread": 0,
    "title": "BRIEF-Celsion Phase III Clinical Study Of Thermodox In Combination With Radiofrequency Ablation To Continue According To Protocol",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 9, 2018 / 1:10 PM / Updated 5 minutes ago BRIEF-Celsion Phase III Clinical Study Of Thermodox In Combination With Radiofrequency Ablation To Continue According To Protocol Reuters Staff 1 Min Read \nApril 9 (Reuters) - Celsion Corp: \n* PHASE III CLINICAL STUDY OF THERMODOX IN COMBINATION WITH RADIOFREQUENCY ABLATION TO CONTINUE ACCORDING TO PROTOCOL Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)",
    "published": "2018-04-09T16:09:00.000+03:00",
    "crawled": "2018-04-09T16:22:00.032+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "pm",
        "updated",
        "minute",
        "ago",
        "phase",
        "iii",
        "clinical",
        "study",
        "thermodox",
        "combination",
        "radiofrequency",
        "ablation",
        "continue",
        "according",
        "protocol",
        "reuters",
        "staff",
        "min",
        "read",
        "april",
        "reuters",
        "celsion",
        "corp",
        "phase",
        "iii",
        "clinical",
        "study",
        "thermodox",
        "combination",
        "radiofrequency",
        "ablation",
        "continue",
        "according",
        "protocol",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}